effect of rasona pinda with katibasti in the treatment of grudhrasi(sciatica)

“Comparative Evaluation of Efficacy of Trayodashang Guggul Versus Rasona Pinda as an adjuvant With Katibasti in the management Of Grudhrasi (Sciatica): A Randomized Controlled Trial ?

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/048534

Enrollment

Registered

2022-12-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient willing to participate with written informed consent. 2 Patients aged between 20-60 years. 3 Patients having clinical signs and symptoms of Grudhrasi

Exclusion criteria

Exclusion criteria: 1 Cases of Traumatic injury. 2 Known cases of Bone tumour, CA of Spine., Tuberculosis of vertebral column, Fibrosis of sacral ligaments, and Protruded Inter vertebral Disc. 3 Patients suffering from systemic diseases like Diabetes mellitus, Heart disease, Renal disease, Cancer, Tuberculosis and other major health problems.

Design outcomes

Primary

Measure	Time frame
to assess the efficacy of Rasona pinda and trayodashang guggul on stiffness,pricking pain,numbness,anorexia,drowsiness,Functional disability – Timepoint: 30 days	—

Secondary

Measure	Time frame
To assess efficacy of rasona pinda and Trayodashang guggul on SLRT,Waliking timeTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Mayank Mahendra Kumar Rai

Datta Meghe Institute Of Medical Sciences

sadhanamisar@gmail.com9763732083

Outcome results